The N-stearoylethanolamine effect on the no-synthase way of nitrogen oxide formation and phospholipid composition of erythrocyte membranes in rats with streptozotocine diabetes

Ukrain'skyi Biokhimichnyi Zhurnal

Volumn 79, Issue 6, 2007, Pages 53-59

  Kosiakova, G V ^a   Gulaya, N M ^a  

^a PALLADIN INSTITUTE OF BIOCHEMISTRY   (Ukraine)

Author keywords

Diabetes mellitus; Membrane phospholipids; N stearoylethanolamine; Nitric oxide; NO synthase

Indexed keywords

ETHANOLAMINE DERIVATIVE; N STEAROYLETHANOLAMINE; N-STEAROYLETHANOLAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPID; STEARIC ACID DERIVATIVE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; DRUG EFFECT; ENZYMOLOGY; ERYTHROCYTE MEMBRANE; EXPERIMENTAL DIABETES MELLITUS; MALE; METABOLISM; RAT; WISTAR RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ERYTHROCYTE MEMBRANE; ETHANOLAMINES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPIDS; RATS; RATS, WISTAR; STEARIC ACIDS; STREPTOZOCIN;

RATTUS;

EID: 41849138676     PISSN: 02018470     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Russian source
2. Stelt M., Di Marzo V. // Eur.J.Biochem. -2004. - 271. - P. 1827-1834.
3. Bouaboula M., Hilairet S., Marchand J. et al. // Eur. J. Pharmacol. -2005. - 517, N 3. -P. 174-181.
4. Bor-Kucukatay M.,Wenby R.B., Meiselman H. J., Baskurt O. K. // Am. J. Physiol. Heart. Circ. Physiol. - 2003. - 284. - P. H1577-H1584.
5. Bardell A. L., Macleod K. M. // J. Pharm. Experim. Terapeutics. - 2001. - 296. - P. 252-259.
6. Green L. C., David A. W, Glogowski J. et al. // Anal. Biochem. - 1982. - 126, N 1. - P. 131 138.
7. Bank N. R., Aynedjian H. S. // Kidney Int. -1993. - 43. - P. 1306-1312.
8. Dodge I. L, Mitchel C., Harahan D. I. // Arch. Biochem. Biophys. - 1963. - 100, N 1. -P. 119-130.
9. Bligh E. C., Dyer W. I. // Can. J. Biochem. Physiol. - 1959. - 37, N 8. - P. 911-917.
10. Svetashev V. I., Vaskovsky V. E. // J. Chromatogr. - 1972. - 67. - P. 376-378.
11. Vaskovsky V. E., Kostetsky E. Y., Vasendin I. M. // Ibid. - 1975. - 114. - P.129-141.
12. Shin S., Ku Y., Babu N., Singh M. // Indian J. Exp. Biol. - 2007. - 45, N 1. - P. 121-128.
13. Nakano T., Wada Y., Matsumura S. // Clin. Hemorheol. Microcirc. - 2001. - 24, N 2. -P. 85-92.
14. Ambrosini A., Tanfani F., Bertoli E. et al. // Chem. Phys. Lipids. - 1993. - 65. - P. 165-169.
15. Zolese G., Wozniak M., Mariani P. et al. // J. Lipid Res. - 2003. - 44. - P. 742-753.
16. Russian source
17. Vaughn M. W., Huang K. T., Kuo L., Liao J. C. H Nitric Oxide - 2001. - 5, N 1. - P. 18-31.
18. Kleinbongard P., Schulz R., Rassal T. et al. // Blood. - 2006. - 107, N 1. - P. 2943-2951.
19. Kahn N. N., Acharya K, Bhattacharya S. et al. // IUBMB Life. - 2000. - 49. - P. 441-450.
20. Bhattacharya S., Chakraborty P. S., Basu R. S. et al. //Arch. Physiol. Biochem. - 2001. - 109, N 5. - P. 441-449.
21. Higaki Y., Hirshman M. F, Fujii N., Goodyear L. J. // Diabetes. - 2001. - 50, N 2. -P. 241-247.
22. De Oliveira E. M., Tavares L. W., Vannuchi Y. B. et al. // Eur. J. Pharmacol. -1999. - 367. -P. 307-314.
23. Zou M. N., Cochen R., Ulrich V. // Endothelium. - 2004. - 11, N 2. - P. 89-97.
24. Stefano G., Sazlet M., Magazine H., Bilfinger T. // J. Cardiovasc. Pharmacol. - 1998. - 31. -P. 813-820.
25. Bilfinger T., Sazlet M., Fimiani C. et al. //Int. J. Cardiol. - 1998. - 64, Suppl. 1. - P. S15-S22.
26. Kamlekar R. K, Swamy M. J. // J. Lipid Res. -2006. - 47, N 7. - P. 1424-1433.